IP Licensing and Antitrust Law – What Companies Have to Consider When Doing Business in the U.S. and the EU
Welcome to Mofo Life Sciences
MoFo Life Sciences shares timely legal and business insights and in-depth analyses on trends and the complex technologies at the heart of the global pharmaceutical, biotechnology, diagnostics, medical devices, digital health, and AgTech fields.
- In both the U.S. and the EU, it is generally acknowledged that the enforcement and commercialization of IP rights must comply with the applicable antitrust laws. This is particularly true for IP licensing. While the majority of provisions in license arrangements will not be... ›
Harmonization of Trade Secrets in Europe and New U.S. Trade Secrets Law Gets the Green Light
By: Alistair Maughan, Wolfgang Schönig and Bryan WilsonA harmonized trade secrets protection regime is coming to Europe and the U.S. Until now, the approach to trade secrets across Europe has been fragmented, with some countries having specific trade secrets legislation and others relying on unfair competition, tort, or contract law. Trade... ›
Cancer Moonshot: USPTO Extends Cancer Immunotherapy Pilot Program Initiative
By: Karen G Potter Ph.D.The United States Patent and Trademark Office (PTO) issued a Notice today extending the Cancer Immunotherapy Pilot Program (Pilot Program), also known as “Patents 4 Patients.” The Pilot Program, which accelerates the examination of patent applications directed to cancer immunotherapy methods, will now expire... ›